European Reimbursement/Germany

Germany · DiGA · Permanent

elevida

GAIA AG

About this entry

elevida is a digital health app from GAIA AG with a permanent DiGA listing in Germany's DiGA directory (BfArM id 00419). It is indicated for Multiple Sklerose [Encephalomyelitis disseminata]. First listed on 2020-12-15. The public prescription price is EUR 243 for a 90-day unit. German statutory health insurers reimburse prescribed use under the Digital Healthcare Act rules. This page is not legal or reimbursement advice; confirm the current entry on the official BfArM listing.

App
elevida
Maker
GAIA AG
Country
Germany
Program
DiGA
Status
Permanent
Indication detail
G35 Multiple Sklerose [Encephalomyelitis disseminata]; F20 Schizophrenie; F23 Akute vorübergehende psychotische Störungen; F25 Schizoaffektive Störungen; F31 Bipolare affektive Störung; +1 more
Indication codes
G35, F20, F23, F25, F31, R45.8
Listing date
2020-12-15
Public price
EUR 243.00 per 90-day unit
BfArM DiGA id
00419

Not legal or reimbursement advice. Confirm the current entry with the official source.